Predict your next investment

Corporation
CONSUMER PRODUCTS & SERVICES
cannamericabrands.com

See what CB Insights has to offer

Founded Year

2017

Stage

IPO | IPO

Date of IPO

10/15/2018

Market Cap

0.00B

About CannAmerica Brands

CannAmerica Brands (CSE:CANA) (CNSX:CANA.CN) (OTC:CNNXF) is a cannabis branding, licensing and intellectual property company with a portfolio of premium cannabis brands in the United States.

CannAmerica Brands Headquarter Location

16th Floor, 595 Burrard Street

Vancouver, British Columbia, V7X 1L4,

Canada

314-495-4589

Latest CannAmerica Brands News

CannAmerica Provides Corporate Update

Jan 12, 2022

CannAmerica Provides Corporate Update News VANCOUVER – TheNewswire – January 12, 2022 – CANNAMERICA BRANDS CORP. (“CannAmerica Brands” or the “Company”) (CSE:CANA) (CNSX.CANA.CN) (OTC:CNNXF) is pleased to provide a corporate update on the Company’s activities. During the last year, the Company has focused on increasing its Colorado gummy sales to pre-pandemic (2019) levels. Through the planned Merger and Acquisition of the licensed partner, Arsenal Oils and Extracts, LLC (“Arsenal”) at the end of 2021 (see news releases dated December 16 and December 22, 2021) and the management agreement in place since January 1, 2022, CannAmerica Brands Corp. will now capture the revenues of all Arsenal’s Colorado sales, including its additional brands of popular vape cartridges and CannAmerica edibles. Through controlling the management of the business in the transition and required regulatory approval period by all government agencies that control licensed cannabis operations and the CSE, the Company will create growth for the brand and the business with an increased focus on the promotion of all brands under the Company’s control. During the next quarter the Company intends to increase sales, create a focus on marketing current as well as new products and apply for a medical marijuana manufacturer of infused products license in Colorado. Arsenal currently has a recreational license in Colorado, by adding a medical license the Company projects an additional $2 million in sales from the medical market in Colorado for 2022, bringing projected sales in Colorado to $4.6 million annually resulting in annual gross profits of $1,426,000, based on gross margins of 31%. The Company also plans to acquire a larger building in Colorado in 2022, for manufacturing and additional extraction technologies to add to the Company’s concentrates menu, as well as a large kitchen for expanding the Company’s edible product lines and a beverage bottling line to introduce a variety of beverages, initially into the Colorado marketplace. The Company anticipates distributing the expanded product offerings into the other markets in which CannAmerica Brands operates as part of a two-year growth plan. The growth plan includes the acquisition of operators in multiple states, with assets including vertical integration of cultivation, manufacturing and retail dispensaries, in order to transform the business of the Company from a multi-state licensor to a multi-state operator. The Board of Directors of the Company are focused on expanding the Board, the management team and operations by recruiting experienced professionals with national cannabis and hemp retail expertise to increase the Company’s supply chain and increase distribution of the Company’s branded products. Mr. Dan Anglin, President and Chief Executive Officer commented “I am extremely proud of the accomplishments of the Company’s personnel and licensing partners since founding the Company in 2015. There have been many challenges in the last two years. The largest impact of the pandemic for management has been the increased time it takes to accomplish the goals we set for the Company. The acquisition and management agreement with Arsenal gives the Company the momentum to begin working on additional business combinations to improve CannAmerica Brands market position and create true value for the stakeholders.”   The Company is proposing to issue 3,000,000 Common Shares to certain directors, officers and consultants of the Company at a deemed price of C$0.10 per share for services provided to the Company during 2021. These persons took severe salary cuts to sustain the Company through the drop in revenues as a result of the pandemic. The Common Shares are being issued at four times over the current market price. The issuance of the Common Shares is subject to the approval of the Canadian Securities Exchange. All Common Shares issued will be subject to a four month hold period under applicable Canadian securities laws. Additionally, the Company and Flower One Holdings Inc. have mutually terminated the Nevada licensing agreement as part of a settlement for licensing fees owed to CannAmerica Brands Corp.   For a more complete business and financial profile of the Company, please view the Company’s website at  www.cannamericabrands.com  and documents posted under the Company’s profile on  www.sedar.com . On Behalf of the Board, Dan Anglin www.cannamericabrands.com   CannAmerica is a U.S. Marine Corps veteran founded and operated portfolio of cannabis brands with licensing agreements in the states of Colorado, Oklahoma, Massachusetts and the Country of Canada. The Company aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally. The Company’s core strategy is to enhance and monetize the global reach of its existing brands, and to pursue additional strategic acquisitions to grow the scope and diversity of its brand portfolio. For more information, please visit  www.cannamericabrands.com . Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information. About Ryan Allway Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies. Search CannabisFN About CFN Media Group CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com. Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/ .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CannAmerica Brands

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CannAmerica Brands is included in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.